Very Soon, Thousands Of Individual Banknotes Of U.S. Paper Currency Could Say ‘Donald J. Trump Protects Pedophiles’
In Trump's America, customized rubber stamps are cheap and plentiful.
You, The Average American Taxpayer, Individually Spent $276.29 This Month To Fund The War Against Iran
And that's just for THIS month.
Keeping Law School Accessible When Federal Loans Fall Short
As federal borrowing caps tighten financing options for law students, one organization is stepping in to negotiate the terms they can't secure alone.
Join The Resist And Unsubscribe Movement, Cancel Your Streaming And AI Services, Punch Back At Trump’s Out-Of-Control ICE
Trump responds to only one thing: the market.
What Experts Say About Hims & Hers’ $1.15B Acquisition Of Eucalyptus
Experts say Hims & Hers’ acquisition of Eucalyptus positions the company for global expansion and revenue diversification amid U.S. GLP-1 regulatory challenges.
Medicare Enrollment For Lawyers: What You Need To Know Before 65
Let's cut through the confusion and focus on what actually matters for your planning.
LexisNexis Practical Guidance Rolls Out Dedicated Practice Area for AI & Technology
The new generation of AI-related legal issues are inherently cross-disciplinary, implicating corporate law, intellectual property, data privacy, employment, corporate governance and regulatory compliance.
The Digital Health M&A Wave Is Finally Here
Digital health is entering a more mature phase in 2026 as consolidation accelerates through targeted M&A, driven by the need for scale, artificial intelligence and pressure from payers, investors say.
Finance Bros Rejoice: Polo Ralph Lauren’s Quarter-Zip Was Fashion’s Hottest Product Of Q4 2025
Saint Laurent, Miu Miu, and Cos maintained their top-three positions as fashion's hottest brands for another quarter.
The 4 Biotech Companies On Track To IPO This Week Despite The Government Shutdown
Across all industries, the total number of companies on track to go public could make this week the most active for IPOs since 2021. Despite the partial government shutdown, there are paths biotechs can pursue to the public markets.
Trump Sues JP Morgan For ‘Nice Bank You Got There, Be A Shame If Something Happened To It’
As shakedowns go, it's pretty shakey.
Protégé™ In CourtLink® Explains The Whole Case Faster
Designed to reduce manual docket work by prioritizing what litigators need most: on-demand full docket summarization that explains the whole case to date, followed by on-demand document summaries for filing triage, and AI-powered natural language searching for faster search and retrieval.
Goldman’s Top Lawyer In The Spotlight Thanks To Epstein Ties
Old associations are resurfacing, raising uncomfortable questions for Wall Street's most powerful bank.
JPM Deals Recap: Boston Scientific Acquisition, A Mega Round For Parabilis, Enodia Emerges & More
Cancer drugs are always popular biotech investments, but autoimmune disease also figures prominently in the startup financings announced during the annual J.P. Morgan Healthcare Conference this year.
Reed: Congress ‘Would Have To’ Codify Trump’s Defense Industry Stock Buyback Mandates
The top SASC Democrat stopped short of supporting Trump's executive order, as a few defense firms said they're on board, at least publicly.
Right-Wing’s Fraud Fever Dreams Will Fade Even As Tim Walz’s Decision To Cede Power Goes Down In History
By putting his state above his own ambitions, Tim Walz has ensured that these MAGA lies will swiftly disappear.
If You Are Applying To Law School And Want A Few Minutes Of Free Financial Or Career Advice, Email Me
We can talk about whatever you'd like, be it the financial calculus of going to law school, or how to best set yourself up for the career you want.